Sol Ferrero, Matías Gatto & Gustavo Helguera. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
28
.
Kirstin A. Zettlitz, Felix B. Salazar, Reiko E. Yamada, K. Ryan Trinh, Alex Vasuthasawat, John M. Timmerman, Sherie L. Morrison & Anna M. Wu. (2022) 89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model. Molecular Cancer Therapeutics 21:4, pages 607-615.
Crossref
Pedro Cecílio, James Oristian, Claudio Meneses, Tiago D. Serafim, Jesus G. Valenzuela, Anabela Cordeiro da Silva & Fabiano Oliveira. (2020) Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle. Scientific Reports 10:1.
Crossref
Oluwaseyi T. Shofolawe-Bakare, Larry D. Stokes, Mehjabeen Hossain, Adam E. Smith & Thomas A. Werfel. (2020) Immunostimulatory biomaterials to boost tumor immunogenicity. Biomaterials Science 8:20, pages 5516-5537.
Crossref
Alina Schneider, Ingo H. Gorr, Vincent Larraillet, Timo Frensing & Oliver Popp. (2019) Reduction of IL‐2 fragmentation during manufacturing of a novel immunocytokine by DoE process optimization. Biotechnology and Bioengineering 116:10, pages 2503-2513.
Crossref
Rosendo Luria-Pérez, Pierre V. Candelaria, Tracy R. Daniels-Wells, José A. Rodríguez, Gustavo Helguera & Manuel L. Penichet. (2019) Amino acid residues involved in the heparin-binding activity of murine IL-12 in the context of an antibody-cytokine fusion protein. Cytokine 120, pages 220-226.
Crossref
Jesse D. Plotkin, Michael G. Elias, Mohammad Fereydouni, Tracy R. Daniels-Wells, Anthony L. Dellinger, Manuel L. Penichet & Christopher L. Kepley. (2019) Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells. Frontiers in Immunology 10.
Crossref
E. Jensen-Jarolim, H. J. Bax, R. Bianchini, S. Crescioli, T. R. Daniels-Wells, D. Dombrowicz, E. Fiebiger, H. J. Gould, S. Irshad, J. Janda, D. H. Josephs, F. Levi-Schaffer, L. O′Mahony, G. Pellizzari, M. L. Penichet, F. Redegeld, F. Roth-Walter, J. Singer, E. Untersmayr, L. Vangelista & S. N. Karagiannis. (2018) AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer. Allergy 73:2, pages 328-340.
Crossref
Juan C. Almagro, Tracy R. Daniels-Wells, Sonia Mayra Perez-Tapia & Manuel L. Penichet. (2018) Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy. Frontiers in Immunology 8.
Crossref
Zahra Valedkarimi, Hadi Nasiri, Leili Aghebati-Maleki & Jafar Majidi. (2017) Antibody-cytokine fusion proteins for improving efficacy and safety of cancer therapy. Biomedicine & Pharmacotherapy 95, pages 731-742.
Crossref
Kuldeep Dhama, Mani Saminathan, Siju Susan Jacob, Mithilesh Singh, K. Karthik, Amarpal .Ruchi Tiwari, Lakshmi Tulasi Sunkara, Yashpal Singh Malik & Raj Kumar Singh. (2015) Effect of Immunomodulation and Immunomodulatory Agents on Health with some Bioactive Principles, Modes of Action and Potent Biomedical Applications. International Journal of Pharmacology 11:4, pages 253-290.
Crossref
Barbara Geering & Martin Fussenegger. (2015) Synthetic immunology: modulating the human immune system. Trends in Biotechnology 33:2, pages 65-79.
Crossref
Gözde Isik, Thijs van Montfort, Nancy P. Y. Chung, John P. Moore & Rogier W. Sanders. (2014) Autoantibodies Induced by Chimeric Cytokine-HIV Envelope Glycoprotein Immunogens. The Journal of Immunology 192:10, pages 4628-4635.
Crossref
Florian Lienert, Jason J. Lohmueller, Abhishek Garg & Pamela A. Silver. (2014) Synthetic biology in mammalian cells: next generation research tools and therapeutics. Nature Reviews Molecular Cell Biology 15:2, pages 95-107.
Crossref
Martin Siegemund, Fabian Richter, Oliver Seifert, Felix Unverdorben & Roland E. Kontermann. 2014. Monoclonal Antibodies. Monoclonal Antibodies
273
295
.
Kewal K. JainKewal K. Jain. 2014. Applications of Biotechnology in Oncology. Applications of Biotechnology in Oncology
371
391
.
Hui Ding, Gustavo Helguera, José A. Rodríguez, Janet Markman, Rosendo Luria-Pérez, Pallavi Gangalum, Jose Portilla-Arias, Satoshi Inoue, Tracy R. Daniels-Wells, Keith Black, Eggehard Holler, Manuel L. Penichet & Julia Y. Ljubimova. (2013) Polymalic acid nanobioconjugate for simultaneous immunostimulation and inhibition of tumor growth in HER2/neu-positive breast cancer. Journal of Controlled Release 171:3, pages 322-329.
Crossref
Leslie A. Khawli, Peisheng Hu & Alan L. Epstein. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
295
314
.
Stefan R. Schmidt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
253
269
.
Stefan R. Schmidt. 2013. Fusion Protein Technologies for Biopharmaceuticals. Fusion Protein Technologies for Biopharmaceuticals
1
24
.
Rangaiah Shashidharamurthy, Erica N. Bozeman, Jaina Patel, Ramneet Kaur, Jeyandra Meganathan & Periasamy Selvaraj. (2011) Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development. Medicinal Research Reviews 32:6, pages 1197-1219.
Crossref
Roland E. Kontermann. (2012) Antibody–cytokine fusion proteins. Archives of Biochemistry and Biophysics 526:2, pages 194-205.
Crossref
Slava Stamova, Stefanie Koristka, Juliane Keil, Claudia Arndt, Anja Feldmann, Irene Michalk, Holger Bartsch, Claudia C. Bippes, Marc Schmitz, Marc Cartellieri & Michael Bachmann. (2012) Cancer Immunotherapy by Retargeting of Immune Effector Cells via Recombinant Bispecific Antibody Constructs. Antibodies 1:2, pages 172-198.
Crossref
Andreas A. Hombach & Hinrich Abken. 2012. Antibody Engineering. Antibody Engineering
611
626
.
Jaheli Fuenmayor & Ramon F. Montaño. (2011) Novel Antibody-Based Proteins for Cancer Immunotherapy. Cancers 3:3, pages 3370-3393.
Crossref
Masaaki Tamura, Deryl Troyer, Dharmendra Maurya, Atsushi Kawabata & Raja Rachakatla. 2011. Cytokines. Cytokines
173
187
.
Patrick Williams & Jacques Galipeau. (2011) GM-CSF–Based Fusion Cytokines as Ligands for Immune Modulation. The Journal of Immunology 186:10, pages 5527-5532.
Crossref
Jonas Winter, Karin Barbin, Camilla Bacci & Thomas Bunte. (2011) A new bioassay for the immunocytokine L19-IL2 for simultaneous analysis of both functional moieties. Journal of Pharmaceutical and Biomedical Analysis 54:1, pages 81-86.
Crossref
Jaheli Fuenmayor, Karin Perez-Vazquez, Daniel Perez-Witzke, Manuel L. Penichet & Ramon F. Montano. (2010)
Decreased Survival of Human Breast Cancer Cells Expressing HER2/
neu
on
In vitro
Incubation with an Anti-HER2/
neu
Antibody Fused to C5a or C5adesArg
. Molecular Cancer Therapeutics 9:8, pages 2175-2185.
Crossref
Dafne Müller & Jeannette Gerspach. 2010. Antibody Engineering. Antibody Engineering
113
126
.
Michael C. FlickingerGustavo Helguera, Tracy R. Daniels, José A. Rodríguez & Manuel L. Penichet. 2009. Encyclopedia of Industrial Biotechnology. Encyclopedia of Industrial Biotechnology.
Roberto Ronca, Silvano Sozzani, Marco Presta & Patrizia Alessi. (2009) Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case. Immunobiology 214:9-10, pages 800-810.
Crossref
Daila S. Gridley, James M. Slater, Xian Luo-Owen, Asma Rizvi, Stephen K. Chapes, Louis S. Stodieck, Virginia L. Ferguson & Michael J. Pecaut. (2009) Spaceflight effects on T lymphocyte distribution, function and gene expression. Journal of Applied Physiology 106:1, pages 194-202.
Crossref